Daniel Saltzstein, MD
NPI 1922088947 · Urology Physician · San Antonio, TX
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1922088947
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- H2005 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
9,020 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Nucleic Acid for Organism, Amplified Probe Technique87798 | 1,224 | $34 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 1,149 | $16 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 929 | $121 |
| Manual Urinalysis Test With Examination Using Microscope, Automated81001 | 922 | $3 |
| Psa (prostate Specific Antigen) Measurement, Total84153 | 858 | $18 |
| Ultrasound Measurement of Bladder Capacity After Voiding |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 38 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 1,136 | 308 |
| Finasteride | 818 | 241 |
| Relugolixbrand: Orgovyx | 644 | 83 |
| Apalutamidebrand: Erleada | 275 | 34 |
| Mirabegronbrand: Myrbetriq | 233 | 68 |
| Abiraterone Acetate | 206 | 23 |
| Alfuzosin Hclbrand: Alfuzosin Hcl Er | 204 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$65,868 across 88 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-17
- Last updated
- 2018-10-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.